company

NORBIOTECH AS

1397 NESØYA

Return on Equity
−260 %
Current Ratio
1,23
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue336 000
Net Income−52 000
Total Assets80 000
Total Equity20 000
Income (NOK)2022
Revenue336 000
Expenditure307 000
Operating Profit29 000
Financial Income0
Financial Costs49 000
Financial Balance−49 000
Earnings Before Tax−20 000
Tax32 000
Net Income−52 000
Balance (NOK)2022
Total Fixed Assets6 000
Total Current Assets74 000
Total Assets80 000
Total Retained Equity1 000
Total Equity20 000
Total Long-Term Debt0
Total Current Debt60 000
Total Equity and Debt80 000
Cash flow (NOK)2022
Sales Income0
Other Income336 000
Revenue336 000
Cost of Goods Sold0
Salary Costs0
Depreciation9 000
Impairment0
Expenditure307 000
Operating Profit29 000
Financial Income0
Financial Costs49 000
Financial Balance−49 000
Dividends0
Net Income−52 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures6 000
Total Tangible Assets6 000
Total Fiancial Fixed Assets0
Total Fixed Assets6 000
Stock0
Total Investments59 000
Cash, Bank13 000
Total Current Assets74 000
Total Assets80 000
Total Equity20 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors2 000
Unpaid Taxes1 000
Dividends0
Other Current Debt57 000
Total Current Debt60 000
Total Equity and Debt80 000
Financial indicators2022
Return on Equity−260 %
Debt-to-Equity Ratio0
Operating Profit Margin8,63 %
Current Ratio1,23
Quick Ratio1,23
Equity Ratio0,25
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English